Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Automated DNA Probe Tests for HLA Disease
U'Ren, Jack R.
Epoch Biosciences, Inc., Bothell, WA, United States
Search 15 grants from Jack U'Ren
Search grants from Epoch Biosciences, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Computer and Statisical Support Services
MESA Family Study - Columbia University Field Center
Hepatic Gene Transfer for the Treatment of Hemophilia B
Neuroendocrine Regulation of Growth
Caffeine Influences on Exercise and Psychological Stress
Recently added grants:
Animal Studies Core
Nanoscale programing of cellular and physiological phenotypes
The biosynthesis of N-N bond-containing natural products
Molecular and evolutionary genetics of retrotransposon-mediated interspecific hybrid incompatibility in Drosophila
Clinical Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44DK045547-03
Application #
2144777
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (05))
Project Start
1992-09-30
Project End
1996-09-29
Budget Start
1995-09-30
Budget End
1996-09-29
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Epoch Biosciences, Inc.
Department
Type
DUNS #
City
Bothell
State
WA
Country
United States
Zip Code
98021
Related projects
NIH 1995
R44 DK
Development of Automated DNA Probe Tests for HLA Disease
U'Ren, Jack R. / Epoch Biosciences, Inc.
NIH 1994
R44 DK
Development of Automated DNA Probe Tests for HLA Disease
U'Ren, Jack R. / Epoch Biosciences, Inc.
Publications
Nepom, G T; Gersuk, V; Nepom, B S
(1996)
Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis.
J Rheumatol Suppl 44:5-9
Comments
Be the first to comment on this grant